UEMS Should Develop a Position on Direct-to-Consumer Testing (DTCT): Point of view
European Medical Specialist Review · 07.08.2026
DOI: 10.67452/emsr.2026.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Medical Specialist Review, online erschienen am 07.08.2026. Verfasst von Matthias Orth und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The rapid expansion of direct-to-consumer testing (DTCT) has created a growing market for laboratory analyses performed outside traditional healthcare structures. Although increased public engagement with health and wellbeing is welcome, testing conducted without appropriate medical oversight raises important concerns regarding patient safety, result interpretation, unnecessary medicalisation, and the misuse of healthcare resources.
Objective
This Point of View argues that the Union Européenne des Médecins Spécialistes (UEMS) should develop a clear position regarding DTCT and participate actively in European discussions concerning regulation, patient protection, and medical oversight.
Discussion
Commercial DTCT providers frequently market tests using medical terminology while simultaneously presenting them as lifestyle or wellness products. This blurs the distinction between healthcare and consumer services and may mislead patients regarding the clinical significance of test results. The absence of appropriate medical evaluation, quality-assured interpretation, and follow-up creates risks including false reassurance, unnecessary anxiety, inappropriate investigations, and delayed diagnosis. Regulatory fragmentation across Europe further complicates patient protection, particularly given the cross-border nature of many DTCT services. The authors advocate for harmonised European regulation, mandatory labelling standards, restrictions on misleading medical claims, and stronger recognition of the role of medically qualified laboratory specialists.
Conclusions
The UEMS and the wider medical community should actively engage in developing a coordinated European approach to DTCT. Protecting patients requires clear distinctions between medical diagnostics and commercial wellness testing, stronger regulatory frameworks, and preservation of the essential role of medical laboratory expertise in ensuring safe and clinically meaningful testing.
Zitieren
APA
Orth, M., Diness, B. R., & Leegaard, T. (2026). UEMS Should Develop a Position on Direct-to-Consumer Testing (DTCT): Point of view. European Medical Specialist Review. https://doi.org/10.67452/emsr.2026.013
Vancouver
Orth M, Diness BR, Leegaard T. UEMS Should Develop a Position on Direct-to-Consumer Testing (DTCT): Point of view. European Medical Specialist Review. 2026. doi:10.67452/emsr.2026.013
BibTeX
@article{Orth2026,
author = {Orth, Matthias and Diness, Birgitte Rode and Leegaard, Truls},
title = {UEMS Should Develop a Position on Direct-to-Consumer Testing (DTCT): Point of view},
journal = {European Medical Specialist Review},
year = {2026},
doi = {10.67452/emsr.2026.013}
}
EUVIMED